Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
MERS S1 protein, His Tag (Cat. No. S1N-M52H5) immobilized on CM5 Chip can bind Cynomolgus DPPIV, His Tag (Cat. No. DP4-C52H9) with an affinity constant of 60.7 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Teneligliptin Hydrobromide Hydrate/Canagliflozin Hemihydrate | Approved | Mitsubishi Tanabe Pharma Corp, Daiichi Sankyo Co Ltd | Canalia | Japan | Diabetes Mellitus, Type 2 | Daiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma | 2017-07-03 | Diabetes Mellitus, Type 2 | Details | |
Gemigliptin | Approved | Details | ||||||||
Anagliptin/Metformin Hydrochloride | SK-1501 | Approved | Sanwa Kagaku Kenkyusho Co Ltd, Suzuken | Metoana | Japan | Diabetes Mellitus, Type 2 | Sanwa Kagaku Kenkyusho Co Ltd | 2018-09-21 | Diabetes Mellitus, Type 2 | Details |
Dapagliflozin Propanediol Monohydrate/Saxagliptin Hydrochloride | Approved | Astrazeneca Plc | Qtern | United States | Diabetes Mellitus, Type 2 | Astrazeneca Ab | 2016-07-15 | Diabetes Mellitus, Type 2 | Details | |
Sitagliptin/Ertugliflozin | Approved | Pfizer Pharmaceuticals Ltd (China) | Steglujan | EU | Diabetes Mellitus, Type 2 | Merck Sharp & Dohme Bv | 2017-12-19 | Diabetes Mellitus, Type 2 | Details | |
Metformin Hydrochloride/Sitagliptin Hydrochloride | Approved | Sandoz Bv | EU | Sandoz Bv | 2019-12-10 | Details | ||||
Evogliptin Tartrate/Metformin Hydrochloride | DA-1229_01 | Approved | Dong-A Pharmaceutical Co Ltd | Sugamet XR | South Korea | Diabetes Mellitus, Type 2 | Dong-A Pharmaceutical Co Ltd | 2015-12-01 | Diabetes Mellitus, Type 2 | Details |
Rosuvastatin Calcium/Gemigliptin L-tartrate Sesquihydrate | Approved | Lg Life Sciences Ltd | ZemiStatin | Diabetes Mellitus, Type 2; Dyslipidemias | Details | |||||
Teneligliptin/Pioglitazone | Approved | Glenmark Pharmaceuticals Ltd | Zita Plus Pio | India | Diabetes Mellitus, Type 2 | Glenmark Pharmaceuticals Ltd | 2022-04-25 | Diabetes Mellitus, Type 2 | Details | |
Sitagliptin Phosphate/Metformin Hydrochloride | Approved | Merck & Co Inc | Janumet, Velmetia | Mainland China | Diabetes Mellitus, Type 2 | Msd Pharma (Singapore) Pte Ltd | 2007-03-30 | Diabetes Mellitus, Type 2 | Details | |
Linagliptin/Metformin Hydrochloride | Approved | Boehringer Ingelheim Gmbh | 欧双宁, Jentadueto, Trajenta Duo, Jentadueto Xr | Mainland China | Diabetes Mellitus, Type 2 | Boehringer Ingelheim (Schweiz) Gmbh | 2012-01-30 | Diabetes Mellitus, Type 2 | Details | |
Linagliptin/Empagliflozin | BI 1356/BI 10773; BI 10773/linagliptin; BI 1356/empagliflozin; Empagliflozin/BI 1356; Linagliptin/BI 10773; BI 10773/BI 1356 | Approved | C.H. Boehringer Sohn Ag & Co. Kg | Tradiance, Glyxambi, Esgliteo | United States | Cardiovascular Diseases | Boehringer Ingelheim Gmbh | 2015-01-30 | Diabetes Mellitus, Type 2; Cardiovascular Diseases | Details |
Empagliflozin/Linagliptin/Metformin | Approved | Boehringer Ingelheim Gmbh, Eli Lilly And Company | Trijardy XR | United States | Diabetes Mellitus, Type 2 | Boehringer Ingelheim Gmbh | 2020-01-27 | Diabetes Mellitus, Type 2 | Details | |
Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride | Approved | Handok Inc | Tenelia M SR | South Korea | Diabetes Mellitus, Type 2 | Handok Inc | 2015-11-03 | Diabetes Mellitus, Type 2 | Details | |
Gemigliptin L-tartrate Sesquihydrate/Metformin Hydrochloride | Approved | Lg Life Sciences Ltd | ZemiMet SR | South Korea | Diabetes Mellitus, Type 2 | Lg Life Sciences Ltd | 2015-01-01 | Diabetes Mellitus, Type 2 | Details | |
Gemigliptin L-tartrate Sesquihydrate | LC-150444; LC-15-0444 | Approved | Lg Life Sciences Ltd | Gemiglo, Zemiglo | South Korea | Diabetes Mellitus, Type 2 | Lg Life Sciences Ltd | 2012-06-27 | Diabetes Mellitus, Type 2; Hepatic Insufficiency | Details |
Saxagliptin Hydrochloride/Metformin Hydrochloride | Approved | Astrazeneca Pharmaceutical Co Ltd | 安立格, Komboglyze, Kombiglyze Xr | Mainland China | Diabetes Mellitus, Type 2 | Astrazeneca Ab | 2010-11-05 | Diabetes Mellitus, Type 2 | Details | |
Sitagliptin Phosphate Monohydrate | ONO-5435A; ONO-5435; MK-0431; MK-431; L-000224715 | Approved | Merck Sharp & Dohme Corp | Xelevia, Ristaben, Tesavel, Glactiv, 捷诺维, Januvia | Japan | Diabetes Mellitus, Type 2 | Msd Kk | 2006-10-16 | Gastroparesis; Kidney Failure, Chronic; Diabetes Mellitus; Hyperlipidemias; Carcinoma, Hepatocellular; Inflammation; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Renal Insufficiency, Chronic; Cardiovascular Diseases; Hepatitis C; Hepatic Insufficiency; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Psoriasis; Diabetes Mellitus, Type 1; Graft vs Host Disease; Glucose Intolerance; Insulin Resistance; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Atherosclerosis; Non-alcoholic Fatty Liver Disease; Heart Failure; Diabetes Mellitus, Type 2; Prediabetic State; Cystic Fibrosis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; HIV Infections | Details |
Omarigliptin | MK-3102 | Approved | Merck & Co Inc | Marizev | Japan | Diabetes Mellitus, Type 2 | Merck Sharp & Dohme Corp | 2015-09-28 | Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Diabetes Mellitus | Details |
Sitagliptin Tartrate | Approved | Heumann Pharma GmbH & Co Generica KG | Sitagliptin Heumann 25 mg Filmtabletten | EU | Heumann Pharma GmbH & Co Generica KG | 2020-12-14 | Parkinson Disease | Details | ||
Sitagliptin Hydrochloride | Approved | EU | Diabetes Mellitus, Type 2 | Laboratorios Alter Sa | 2018-11-27 | Diabetes Mellitus, Type 2 | Details | |||
Linagliptin | BI-1356; BI-1356-BS | Approved | Boehringer Ingelheim Gmbh | 欧唐宁, Ondero, Trajenta, Trayenta, Trazenta, Tradjenta | Mainland China | Diabetes Mellitus, Type 2 | Boehringer Ingelheim International Gmbh | 2011-05-02 | Prediabetic State; Diabetes Mellitus, Type 2; Albuminuria; Renal Insufficiency; Schizophrenia; Respiratory Tract Diseases; Coronavirus Disease 2019 (COVID-19); Hypertension; Endocrine System Diseases; Coronavirus Infections; Metabolic Diseases; Hepatic Insufficiency; Glucose Metabolism Disorders; Inflammation; Ventricular Dysfunction, Left; Diabetes Mellitus | Details |
Anagliptin | SK-0403; CWP-0403 | Approved | Sanwa Kagaku Kenkyusho Co Ltd | Suiny, Beskoa | Japan | Diabetes Mellitus, Type 2 | null | 2012-09-28 | Diabetes Mellitus, Type 2 | Details |
Vildagliptin | LAF-237; DSP-7238; LAF-237A; NVP-LAF-237 | Approved | Novartis Pharma Ag | 佳维乐, Equa, Jalra, Galvus, Gliptus, Xiliarx | Mainland China | Diabetes Mellitus, Type 2 | Novartis Europharm Ltd | 2007-09-25 | Diabetes Mellitus, Type 1; Prediabetic State; Diabetes Mellitus, Type 2; Renal Insufficiency; Schizophrenia; Insulin Resistance; Kidney Diseases; Dyslipidemias; Diabetes, Gestational; Diabetes Mellitus | Details |
Alogliptin Benzoate/Pioglitazone Hydrochloride | SYR-322-4833 BL | Approved | Takeda Pharmaceutical Co Ltd | Nesinaact, Oseni, Liovel, Incresync | EU | Diabetes Mellitus, Type 2 | Takeda Pharma A/S | 2011-07-01 | Diabetes Mellitus, Type 2 | Details |
Trelagliptin Succinate | TAK-472; SYR-472; SYR-111472; SYR-111472 succinate | Approved | Takeda Pharmaceutical Co Ltd | Zafatek | Mainland China | Diabetes Mellitus, Type 2 | Sichuan Kelun Pharmaceutical Co Ltd | 2015-03-26 | Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
Alogliptin Benzoate/Metformin Hydrochloride | CT-L01; CT-L-01 | Approved | Takeda Pharmaceutical Co Ltd | Inisync, Kazano, Vipdomet | Japan | Diabetes Mellitus, Type 2 | Takeda | 2013-01-25 | Diabetes Mellitus, Type 2 | Details |
Vildagliptin/Metformin Hydrochloride | LMF-237 | Approved | Novartis Pharma Ag | 宜合瑞, Eucreas, EquMet, Zomarist, Icandra | Japan | Diabetes Mellitus, Type 2 | Novartis Pharma Ag | 2007-11-14 | Diabetes Mellitus, Type 2 | Details |
Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline | MK-0431J | Approved | Merck & Co Inc, Astellas Pharma Inc | Sujanu | Japan | Diabetes Mellitus, Type 2 | null | 2018-03-23 | Diabetes Mellitus, Type 2 | Details |
Alogliptin Benzoate | SYR-322; TAK-322 | Approved | Takeda | Nesina, 尼欣那, Vipidia | EU | Diabetes Mellitus, Type 2 | Takeda Pharma A/S | 2010-04-06 | Diabetes Mellitus, Type 2; Acute Coronary Syndrome; Diabetes Mellitus | Details |
Evogliptin | DA-1229 | Approved | Dong-A Pharmaceutical Co Ltd | Suganon, Sugarnon | South Korea | Diabetes Mellitus, Type 2 | Dong-A Pharmaceutical Co Ltd | 2015-10-02 | Diabetes Mellitus, Type 2; Kidney Diseases; Aortic valve diseases; Liver Diseases | Details |
Teneligliptin Hydrobromide Hydrate | MP-513 | Approved | Mitsubishi Tanabe Pharma | Tenelia, Tenglyn | Mainland China | Diabetes Mellitus, Type 2 | Mitsubishi Pharma Research & Development (Beijing) Co Ltd | 2012-06-29 | Diabetes Mellitus, Type 2 | Details |
Saxagliptin Hydrate | BMS-477118; BMS-477118-11; OPC-262 | Approved | Bristol-Myers Squibb Company | 安立泽, Onglyza | Japan | Diabetes Mellitus, Type 2 | Kyowa Hakko Kirin Co Ltd | 2009-07-31 | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hypoglycemia; Diabetes Mellitus | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
TSL-0319 | TSL-0319 | Phase 1 Clinical | Jiangsu Tasly Diyi Pharmaceutical Co Ltd | Diabetes Mellitus, Type 2 | Details |
WXSHC-071 | WXSHC-071 | Phase 1 Clinical | Dongbao Zixing (Hangzhou) Biological Medicine Co Ltd | Diabetes Mellitus, Type 2 | Details |
Cetagliptin Phosphate | CGT-8012 | Phase 3 Clinical | Cgenetech(Suzhou China) Co Ltd | Diabetes Mellitus, Type 2 | Details |
TQ-05510 | TQ-05510 | Phase 1 Clinical | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Centaurus Biopharma Co Ltd | Diabetes Mellitus, Type 2 | Details |
Augliptin Hydrochloride | Phase 1 Clinical | Shanghai Sun-Sail Pharmaceutical Science & Technology Co Ltd, Nanjing Changao Pharmaceutical Science And Technologyco Ltd | Diabetes Mellitus, Type 2 | Details | |
Carmegliptin | R-1579; RG-1579; DPP-IV(3); RO-4876904; RO-4876904-001 | F. Hoffmann-La Roche Ltd | Details | ||
Linagliptin/Fimasartan Potassium Trihydrate | Boryung Pharmaceutical Co Ltd | Details | |||
Gosogliptin | PF-734200; PF-00734200 | Pfizer Pharmaceuticals Ltd (China) | Details | ||
CPL2009-0031 | Cadila Healthcare Ltd | Details | |||
Lobeglitazone/Sitagliptin | CKD-396 | Chong Kun Dang Pharmaceutical Corp | Details | ||
Melogliptin | GRC-8200; EMD-675992 | Glenmark Pharmaceuticals Ltd | Details | ||
BMS-767778 | BMS-767778 | Bristol-Myers Squibb Company | Details | ||
Begelomab | SAND-26; BT 5/9 | Phase 2 Clinical | Adienne | Dermatomyositis; Graft vs Host Disease | Details |
TQ-F3083 | TQ-F3083 | Phase 2 Clinical | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Centaurus Biopharma Co Ltd | Diabetes Mellitus, Type 2; Diabetes Mellitus | Details |
Yogliptin | Phase 3 Clinical | Sichuan Sunheal Pharmaceutical Co Ltd, Chengdu Easton Biopharmaceuticals Co Ltd | Diabetes Mellitus, Type 2 | Details | |
Metformin/Dapagliflozin/Sitagliptin | GMRx4 | Phase 2 Clinical | George Medicines PTY Ltd, George Medicines UK Ltd | Diabetes Mellitus, Type 2 | Details |
DC291407 | DC-407; DC-291407 | Phase 2 Clinical | Cisen Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Diabetes Mellitus, Type 2; Fatty Liver | Details |
Empagliflozin/Metformin/Sitagliptin | Phase 1 Clinical | Taizhou Overseas Pharmaceuticals Co Ltd | Diabetes Mellitus, Type 2 | Details | |
Sitagliptin/Telmisartan | HDDO-16091 + HDDO-16092; HOB-077; HDDO-1609 | Phase 1 Clinical | Hyundai Pharmaceutical Co Ltd | Hypertension; Diabetes Mellitus | Details |
REC-04 | Clinical | Recardio Inc | Cardiovascular Diseases | Details | |
Dutogliptin Tartrate/Metformin Hydrochloride | Phenomix Corporation | Details | |||
Evogliptin Tartrate | LY-05007 | Phase 1 Clinical | Dong-A Pharmaceutical Co Ltd | Diabetes Mellitus, Type 2 | Details |
THDBH-100 | THDBH100; THDBH101 | Phase 1 Clinical | Wuxi Apptec(Shanghai) Co Ltd | Diabetes Mellitus, Type 2 | Details |
Dutogliptin Tartrate | REC-01; PHX-1149; PHX-1149T | Phase 2 Clinical | Phenomix | Diabetes Mellitus, Type 2; Myocardial Infarction; ST Elevation Myocardial Infarction; Kidney Diseases; Leukemia, Myeloid, Acute | Details |
Retagliptin Phosphate/Metformin Hydrochloride | HRX-0701 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd | Diabetes Mellitus, Type 2 | Details |
Bogliptin maleate | HL012MA | Phase 2 Clinical | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences, East China University Of Science And Technology, Shandong Baiji Dichang Pharmaceutical Co Ltd | Diabetes Mellitus, Type 2 | Details |
HSK-7653 | HSK7653; HSK-7653 | Phase 3 Clinical | Liaoning Haisco Pharmaceutical Co Ltd, Sichuan Haisco Pharmaceutical Co Ltd | Diabetes Mellitus, Type 2; Glucose Intolerance; Kidney Diseases | Details |
TOTUM•63 | TOTUM-63 | Phase 3 Clinical | Valbiotis | Diabetes Mellitus, Type 2 | Details |
Dapagliflozin/Sitagliptin | SID-1903; DW-6012 | Phase 1 Clinical | Astrazeneca Sa | Diabetes Mellitus, Type 2 | Details |
Diabetes therapeutic | DBPR-108 | Phase 3 Clinical | Taiwan Shenlong Co Ltd, National Health Research Institutes | Diabetes Mellitus, Type 2; Kidney Diseases; Hepatic Insufficiency | Details |
Fotagliptin Benzoate | FCN-005 | Phase 3 Clinical | Fochon Pharmaceuticals Ltd, Shanghai Fosun Pharmaceutical (Group) Co Ltd | Diabetes Mellitus, Type 2 | Details |
Talabostat | PT-100; BXCL-701 | Phase 2 Clinical | Midatech Pharma Plc, Bioxcel Therapeutics Inc | Neuroblastoma; Melanoma; Leukemia, Lymphocytic, Chronic, B-Cell; Adenocarcinoma; Neoplasms, Germ Cell and Embryonal; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Carcinoma, Pancreatic Ductal; Lung Neoplasms; Carcinoma, Small Cell; Brain Neoplasms; Solid tumours; Sarcoma; Prostatic Neoplasms; Central Nervous System Neoplasms; Neuroendocrine Tumors; Skin Neoplasms; Pancreatic Neoplasms; Kidney Neoplasms; Ovarian Neoplasms; Liver Neoplasms | Details |
This web search service is supported by Google Inc.